Delivery Order SPE2DB22D2214-SPE2DB25FS5WC
- Not listed
- The Defense Logistics Agency awarded a $75,338.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.31 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed-price, competitively awarded contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The vaccine will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 0.5ML Boostrix TDAP vaccine syringes with a contract value of $1,330.50 on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,330.50 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,319.30 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. The contract employs firm fixed pricing with no set-aside designation and an ultimate completion date of July 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this competitively awarded delivery order, which is issued under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ml syringes, with a contract value of $1,890.22. This non-set-aside delivery order, awarded on August 11, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 12, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving the company's role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $9,491.76 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at approximately $31K to AmerisourceBergen Drug Corp for supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,694.75 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $133,843.21 on August 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is executed under...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5WCDelivery Order
The Defense Logistics Agency awarded a $15,835.86 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format, with a completion date of July 23, 2025. This non-competitive delivery order represents a firm fixed price contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under the SPE2DX vehicle, this delivery order supports the Defense Health Agency's pharmaceutical supply chain for military healthcare systems. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, providing a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to fulfill defense medical logistics requirements, including specialty medications, brand-name and generic drugs, and vaccines needed to support military personnel and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 7/22/25 |